. 2021 Jun 18;23(6):941–951. doi: 10.1007/s11307-021-01621-0

Table 2.

Selected tissue distribution and tumor to background ratios at Day 9, expressed as percent injected dose per gram (% ID/g ± SEM) from ex vivo gamma counting analysis

Treatment	Blood	Muscle	Tumor	Tumor/blood ratio	Tumor/muscle ratio
0.03 mg/kg PF-07062119	2.03 ± 0.16	0.61 ± 0.10	8.67 ± 0.54	4.3	14.1
0.1 mg/kg PF-07062119	1.78 ± 0.15	0.54 ± 0.16	11.3 ± 1.42	6.3	20.9
1 mg/kg PF-07062119	1.51 ± 0.11	0.47 ± 0.15	13.0 ± 1.10	8.6	27.8
1 mg/kg PF-07079699 (control)	2.12 ± 0.22	0.49 ± 0.18	7.98 ± 1.22	3.8	16.5

Treatment

Blood

Muscle

Tumor

Tumor/blood ratio

Tumor/muscle ratio

0.03 mg/kg

PF-07062119

2.03 ±

0.16

0.61 ±

0.10

8.67 ±

0.54

4.3

14.1

0.1 mg/kg

PF-07062119

1.78 ±

0.15

0.54 ±

0.16

11.3 ±

1.42

6.3

20.9

1 mg/kg

PF-07062119

1.51 ±

0.11

0.47 ±

0.15

13.0 ±

1.10

8.6

27.8

1 mg/kg

PF-07079699 (control)

2.12 ±

0.22

0.49 ±

0.18

7.98 ±

1.22

3.8

16.5